Skip to main
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 19%
Hold 63%
Sell 0%
Strong Sell 6%

Bulls say

Inspire Medical Systems is in a strong position for long-term growth because of their dominance in the HGNS market and the launch of their next-gen Inspire V device. While their recent financials have been weak due to coding uncertainty and WISeR program impact, management expects a return to revenue growth in 2027 and a recovery in the second half of 2021. Additionally, Inspire's favorable valuation and improved execution potential make them an attractive investment opportunity.

Bears say

Inspire Medical Systems is facing challenges in the short-term due to reimbursement and coding issues, and these issues are likely to affect the company's growth trajectory for the next few quarters. Despite its strong technology and market position, the company is currently facing headwinds that could hinder its ability to ramp up profitability. The company's recent guidance cut and slow growth outlook, coupled with ongoing uncertainties, warrant a more cautious approach to the stock.

INSP has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 19% recommend Buy, 63% suggest Holding, 0% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 16 analysts, INSP has a Hold consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.